Phase 1/2 trial of pemetrexed and cisplatin with concurrent thoracic radiation for stage III inoperable nonsquamous non-small cell lung cancer
Phase 1
- Conditions
- on small cell lung cancer
- Registration Number
- JPRN-UMIN000003632
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
1)Active systemic infection 2)Pregnancy or lactation 3)Ascitic fluid or pleural effusion 4)Pericardial fluid retention 5)Peripheral neuropathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phase 1:Dose Limiting Toxicity, Maximum Tolerated Dose Phase 2:Response rate
- Secondary Outcome Measures
Name Time Method Phase 1:Response rate Phase 2:Toxicity, Median survival time